Brain Tumor Pathology

Papers
(The median citation count of Brain Tumor Pathology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu53
Preface for Brain Tumor Pathology vol.41 issue 219
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation19
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma16
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas16
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature15
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis14
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next13
Targeting TGF-β signaling in glioblastoma: therapeutic implications and novel drug development strategies12
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma11
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment10
Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis10
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation9
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lym9
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors9
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next9
Preface for Brain Tumor Pathology vol. 39 issue 28
Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report6
Three-dimensional visualization of human brain tumors using the CUBIC technique6
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles6
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis6
Gyriform infiltration indicates tumor invasion burden of isocitrate dehydrogenase 1/2-wildtype gliomas6
Meningioma with trabecular architecture: a harbinger of BAP1 deficiency5
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas5
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report5
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis4
Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant4
Activated astrocytes drive the accumulation of apolipoprotein E at the brain tumor edge4
Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation4
Astroblastoma with MN1::BEND2 in an elderly patient: A case report and review of the literature4
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma4
Triple sellar collision lesion: a unique case of pituitary adenoma, Rathke cleft cyst, and xanthogranuloma—case report and systematic review of the literature4
Ataxin-2 as a candidate blood biomarker for estimating disease status in cases of suspected glioblastoma recurrence4
Reappraisal of novel molecular parameters for meningioma grading by cIMPACT-NOW update 8 proposals4
Timing of H3K27me3 loss in secondary anaplastic meningiomas4
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment4
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas4
Histopathological evaluation of dopamine receptor D2 expression in symptomatic gonadotroph pituitary neuroendocrine tumors: a case series including a rare metastatic case responsive to a dopamine agon4
A case of primary papillary epithelial tumor of the sella with reverse polarity and paired box 8 expression3
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the T3
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment3
Emerging glioneuronal and neuronal tumors: case-based review3
Progression of long-term “untreated” oligodendroglioma cases: possible contribution of genomic instability3
Aggressive nonfunctioning pituitary neuroendocrine tumors3
How is rosette formation in brain tumours linked with cerebrospinal fluid spread?3
A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL2
Emergence of NEC features in corticotroph PitNETs: primary tumor, radiation-induced transformation, or metastasis?2
Liquid biomarkers in glioma2
An extracranial CNS presentation of the emerging “intracranial” mesenchymal tumor, FET: CREB-fusion positive2
Visualizing the endothelial glycocalyx in human glioma vasculature2
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature2
Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology2
Comprehensive molecular characterization of craniopharyngiomas using whole transcriptome and spatial transcriptomics approaches2
Correction to: Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature2
0.016693830490112